Chair: John Maguire, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia

Gray Zones in Brain Tumor Classification: Evolving Concepts

Arie Perry, Washington University School of Medicine, St. Louis, Missouri

Click here for Objectives of this presentation

At the conclusion of this session, participants will:
• Be familiar with recent changes in the WHO 2007 classification scheme of CNS tumors.;
• Appreciate some of the remaining “gray zones” in the nomenclature and diagnostic workup of CNS tumors.
-------------------------------------------

Click here: Dr. Arie Perry biography

Arie Perry
Dr. Perry is a Professor of Pathology within the Neuropathology Division at Washington University School of Medicine in St. Louis. He received his MD and AP/CP residency training at the U. Texas Southwestern Medical Center in Dallas, TX, followed by fellowships in Surgical Pathology, Neuropathology, and Molecular Cytogenetics Research at the Mayo Clinic in Rochester, MN. He maintains busy in-house and consultation services focused most heavily on Surgical Neuropathology cases, particularly brain tumors. His research is clinical/translational in nature and focuses on classification, grading, and biomarker development for a wide variety of brain tumor subtypes. He is probably best known for his studies leading to the revised 2000 and 2007 WHO criteria for meningioma grading and his use of molecular diagnostics in gliomas, such as oligodendroglioma and the small cell variant of glioblastoma. He is a frequently invited speaker and also serves as the medical director of the Anatomic Pathology FISH lab at Washington U. and the chief editor of Brain Pathology, the official journal for the International Society of Neuropathology. Dr. Perry has received several teaching awards, no doubt related in part to his unique and fun approach to educating second year medical students by combining his passions for music and medicine in the form of "Neuropathology Songs".
-------------------------------------------

Advances in Frontotemporal Dementia

John Woulfe, The Ottawa Hospital, Ottawa, Ontario

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Summarize the (changing) classification of frontotemporal dementia;
• List two novel findings relevant to our increased understanding of the pathogenesis of FTD;
• Discuss the possible role of TDP43 in the pathogenesis of FTD.
-------------------------------------------

Click here: Dr. John Woulfe biography

John Michael Woulfe
Dr. Woulfe obtained his Honours Bachelor of Science from McMaster University, with a major in Biology and Psychology. He then went on to complete a Master of Science at the University of Western Ontario and a PhD (with Honours) from McGill University. Dr. Woulfe obtained his MD from McMaster University. He is currently an Associate Scientist at the Ottawa Health Research Institute in the Cancer Research Program.
-------------------------------------------

Creutzfeldt-Jakob Disease: A Review of Histology, Epidemiology, and the Transmissibility in the Pathology Lab Setting

Gerard Jansen, The Ottawa Hospital, Ottawa, Ontario

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• List the histological features of the most common subtypes of Creutzfeldt-Jakob disease and other prion diseases;
• List the histological mimickers of Creutzfeldt-Jakob disease;
• Discuss the rational and irrational aspects of potential occupational transmission of Creutzfeldt-Jakob disease in the histology laboratory.
-------------------------------------------

Click here: Dr. Gerard H. Jansen biography

Gerard Harm Jansen
Dr. Jansen studied at the Rijks Universitair Centrum Antwerpen Medical Faculty and the Utrecht University Medical Faculty in Belgium. Dr. Jansen, along with Dr. Woulfe, is currently responsible for the covering of the neuropathological service to the neurosurgical and neurological departments of the Ottawa Hospital, both at the General and Civic Campuses in Ottawa. His activities at the Public Health Agency of Canada and the Ottawa Health Research Institute are focused on the clinical aspect of the surveillance for Creutzfeldt-Jakob disease. He is one of the principle investigators of the CJD surveillance system. His position at the University of Ottawa is focused on the pathological aspect of the same disease, and teaching medical students and residents in Neuropathology in general.
-------------------------------------------

Co-Chairs:
Indrojit Roy, St. Mary’s Hospital, Montreal, Quebec
Hallgrimur Benediktsson, University of Calgary, Calgary, Alberta

Challenges of Pathology Practice in Tanzania

Peter Rambau, Bugando University College of Health Sciences, Mwanza, Tanzania

Click here: Dr. Peter F. Rambau biography

Peter F. Rambau
My name is Peter Fabian Rambau born on 15th of August 1972 in Tanzania Kilimanjaro rural area. I did my primary school education in my village for 7 years which I completed on 1986. Then I joined Secondary school in our village for four years which I completed on 1990, and then I joined advanced Secondary education for two years which I completed on 1993 in Moshi Urban area. I joined University of Dar es Salaam on 1994 for MD degree which I completed on 1999 and awarded Degree in Doctor of Medicine. I did my internship at Bugando Medical center for one year, and then I worked as a doctor in the department of Surgery and later on in Paediatrics. I used also to teach Assistant medical Officer during my work. On 2003 I joined Makerere University for three years and awarded Master on Medicine (M.MED) in Pathology. Currently I am working as Lecturer in Pathology Department in Bugando Universtiy College of health Sciences and as a pathologist in Bugando Hospital. I have special interest in Breast Pathology.
-------------------------------------------

Click here for Objectives of this presentation

• To know the situation of pathology set up in Tanzania;
• To understand work burden, challenges in pathology practice;
• To share some interesting cases from Tanzania.
-------------------------------------------

Six Months in Afghanistan – The Pathology Scene

John Deck, Professor Emeritus, University of Toronto, Toronto, Ontario

Click here for Objectives of this presentation

At the conclusion of this session, participants will:
• Appreciate the early stage of development of pathology services in Afghanistan.
-------------------------------------------

Click here: Dr. John Deck biography

John Deck
Dr. Deck is a Fellow of the Royal College of Physicians and Surgeons in General Pathology and neuropathology. He was on staff at the Toronto Western and Toronto General Hospitals and is currently Professor Emeritus at the University of Toronto.
-------------------------------------------

Heinz Hoenecke, Pathologists Overseas, Del Mar, California

Click here for Objectives of this presentation

At the conclusion of this session, participants will:
• Understand the need for pathologists in developing countries on the basis of both Dr. Hoenecke’s clinical and pathology experience since 1989;
• Learn about the various means of providing help for the pathology needs in developing countries;
• Understand the practicalities in providing manpower and material help;
• Learn about the rewards from the standpoint of altruistic, intellectual, and Dr. Hoenecke’s personal experience.
-------------------------------------------

Click here: Dr. Heinz Hoenecke biography

Heinz Hoenecke
Dr. Hoenecke is a graduate of the University of Michigan Medical School in Ann Arbor and has done his pathology residencies in both Michigan and Arizona. He was Board Certified in Anatomical and Clinical Pathology in 1960. He practiced pathology in Arizona for 17 years and in California for 19 years. He founded Pathologists Overseas in 1991 and has acted as the President of the organization since that time. He volunteered overseas as a clinicians in 1989 and 1990 and has volunteered as a pathologist once or twice a year since 1991.
Dr. Hoenecke is a graduate of the University of Michigan Medical School in Ann Arbor and has done his pathology residencies in both Michigan and Arizona. He was Board Certified in Anatomical and Clinical Pathology in 1960. He practiced pathology in Arizona for 17 years and in California for 19 years. He founded Pathologists Overseas in 1991 and has acted as the President of the organization since that time. He volunteered overseas as a clinicians in 1989 and 1990 and has volunteered as a pathologist once or twice a year since 1991.
-------------------------------------------

The Future of Telepathology for the Developing World

Charles L. Hitchcock, Ohio State University College of Medicine, Columbus, Ohio

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Compare and contrast the technologies involved in telepathology;
• Understand the need for pathologists and pathology support in developing countries;
• List the possible ways that telepathology can help provide pathology support to developing countries.
-------------------------------------------

Click here: Dr. Charles Hitchcock biography

Charles L. Hitchcock
Charles L. Hitchcock, MD, PhD is an Associate Professor-Clinical in the Department of Pathology at The Ohio State University College of Medicine. He is the Vice Chairman of Education; he directs both Autopsy Services and the Thoracic Pathology service in the department. His interests are in applications of various technologies to pathology; with a focus on the application of telepathology to routine diagnosis, education, research, and to global health.
-------------------------------------------

The Canadian Reference Centre for Cancer Pathology: A Historical Perspective 

Jane Thomas, University of Ottawa, Ottawa, Ontario

Click here for Objectives of this presentation

Learning Objectives:
• Discuss the history and role of the Canadian Reference Centre for Cancer Pathology in Canadian Pathology;
• List the functions of the Canadian Reference Centre for Cancer Pathology;
• Explain the origins of the “William Boyd Lectureship”.
-------------------------------------------

Granzyme B: A Key Player in Age-Related Chronic Inflammatory Vasculopathies 

David Granville, Assistant Professor/Canada Research Chair/MSFHR Scholar Department of Pathology & Laboratory Medicine University of British Columbia/St. Paul’s Hospital James Hogg Centre for Cardiovascular and Respiratory Research, Vancouver, British Columbia

Click here for Objectives of this presentation

At the conclusion of this session, participants will:
• Understand the role of granzyme B in apoptosis;
• Have a better understanding as to the potential intracellular and extracellular role of granzyme B in atherosclerosis and aneurysms;
• Have an appreciation of the skin as a potential indicator of cardiovascular health.
-------------------------------------------

Click here: Dr. David Granville biography

David Granville
Dr. David Granville is an Associate Professor/Canada Research Chair at the Providence Heart and Lung Institute at St. Paul’s Hospital, UBC. After his B.Sc., Dr. Granville joined QLT Inc., where he worked in the Immunology and Cell Biology division of Preclinical Pharmacology. His work at QLT was focused on understanding the mode of action by which verteporfin (Visudyne®) kills cells and obliterates abnormal blood vessels in diseases such as cancer and age related macular degeneration (ARMD), the leading cause of blindness in the elderly. Visudyne is now clinically approved for the treatment of ARMD. Dr. Granville completed his Ph.D. in 2000 at UBC and in 2001 he moved to the Scripps Research Institute (La Jolla, CA) to study the role and regulation of cell death in heart attacks. Dr. Granville’s research at Scripps revealed a novel therapeutic target which, when inhibited, could reduce the amount of heart injury caused by heart attacks by up to 60%. Dr. Granville was recruited back to UBC in May, 2003 as a Tier II Canada Research Chair. Dr. Granville is also a Michael Smith Foundation for Health Research Scholar and in 2004 was awarded a Canada Top 40 Under 40™ award by Caldwell and Partners. He also received the 2006 UBC Outstanding Young Alumnus Award, the 2007 SFU Academic Alumnus Award and was a finalist for the 2007 Louis and Arnold Katz Basic Science Prize at the American Heart Association Scientific Sessions. His research at The Heart and Lung Institute at St. Paul’s Hospital has recently discovered a novel enzyme that when inhibited not only reduces atherosclerosis but plays a key role in the aging process itself and age-related tissue degeneration.
-------------------------------------------

Chair: Michael Pollanen, Office of the Chief Coroner for Ontario, Toronto, Ontario

Update: Royal College of Physicians and Surgeons of Canada Subspecialty Certification in Forensic Pathology

Michael J. Shkrum, London Health Sciences Centre, London, Ontario

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Explain the benefits of RCPSC accredited training and certification of forensic pathology fellows for medicolegal death investigation and criminal justice system in Canada;
• Summarize the resources required to train a forensic pathology fellow in a RCPSC accredited program;
• Discuss how the RCPSC “Practice Eligibility Route” will certify pathologists currently in forensic practice.
-------------------------------------------

Click here: Dr. Michael J. Shkrum biography

Michael J. Shkrum
Dr. Shkrum received his Bachelor of Science and Doctor of Medicine from the University of Western Ontario. He is currently a Staff Pathologist at the London Health Sciences Centre and Consulting Medical Staff at St. Joseph’s Health Care in London, Ontario. He is also a Professor at the University of Western Ontario and the Regional Coroner’s Pathologist.
-------------------------------------------

Presented by the Canadian Society of Cytology

Chair: Linda Kapusta, Credit Valley Hospital, Mississauga, Ontario

Canadian Society of Cytology Kulscar Lecture:
The ASCCP’s 2006 Consensus Conference for the Management of Women with Cervical Cytological Abnormalities and Cervical Intraepithelial Neoplasia

Kulscar Lecturer: Terence J. Colgan, Mount Sinai Hospital, Toronto, Ontario

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Understand the role of cytology in the management of women with abnormalities in gynecologic cytology;
• Identify appropriate use of HPV testing;
• Recognize the limitations of colopscopy and biopsy.
-------------------------------------------

Click here: Dr. Terence J. Colgan biography

Terence J. Colgan
Dr. Colgan is an anatomical pathologist, and practicing gynecological pathologist. Currently, he is Head of the Sections of Gynecology and Cyto-Pathology at Mount Sinai Hospital and a Professor in the Departments of Laboratory Medicine and Pathobiology and Obstetrics & Gynecology at the University of Toronto. He is actively involved in both teaching and research in gynecological pathology, and is an editor of the International Journal of Gynecological Pathology, Cancer (Cytopathology), Acta Cytologica, Archives of Pathology and Laboratory Medicine, and Journal of Lower Genital Tract Disease. He is a past Chairman of the Canadian Society of Cytology, the Society of Canadian Colposcopists, and the American Society of Cytopathology’s (ASC) Committee on Centers of Excellence. For a number of years he was a member of the College of American Pathologist’s Cytopathology Resource Committee. Currently, he is a member of the council of the International Academy of Cytology, and Chair of the ASC Educational Development Committee. His primary research interest is preventive oncology, including the screening and diagnosis of genital tract neoplasia, new technologies in cervical screening, hereditary cancer, and the application of proteomics to endometrial disease. Along with Drs. Michael Siu and Alex Romaschin, and with the support of the National Cancer Institute of Canada and Canadian Institutes of Health Research, he has developed a biomarker discovery program using tissue proteomics. His professional website can be visited at: colganpath.ca
-------------------------------------------

HPV: Friend or Foe?

Daniel Fontaine, Eastern Health, St. John’s, Newfoundland

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Explain the impact of HPV testing and vaccination on current screening programs;
• Discuss how new technologies will help with screening programs;
• Compare the benefits/limitations of liquid based cytology to conventional and challenges faced by the gyn cytology community in the future.
-------------------------------------------

Click here: Dr. Daniel Fontaine biography

Daniel Fontaine
Dan started training in cytology in 1985 at the Victoria General Hospital taking a diploma in Cytotechnology. Upon completion of the program he worked at the Regional Hospital in Saint John New Brunswick until returning to school in the early 90’s to eventually enter Medical School at Memorial University of Newfoundland where he graduated in 1998. He then went back to Halifax to do a residence in Anatomical Pathology which he completed in 2003. Eventually settling in St. John’s (home of his wife) where he is currently the Director of Cytopathology at Eastern Health and an Assistant Professor at Memorial University. His interests include Liquid Based Cytology and the use of ancillary tests in an attempt to further refine cytologic diagnoses.
-------------------------------------------

Chair: Laurette Geldenhuys, Queen Elizabeth II Health Science Centre, Halifax, Nova Scotia

Thinking About Medical Error in Pathology and Laboratory Medicine

Kaveh Shojania, University of Ottawa, Ottawa, Ontario

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Know the epidemiology of medical error in general plus in pathology and laboratory medicine in particular;
• Recognize common human and systems contributors to medical error;
• Be familiar with some safety improvements that have worked in pathology and lab medicine.
-------------------------------------------

Click here: Dr. Kaveh Shojania biography

Kaveh Shojania
Dr. Kaveh Shojania is the Canada Research Chair in Patient Safety and Quality Improvement and Associate Professor of Medicine at the University of Ottawa. Dr. Shojania’s research focuses on identifying evidence-based patient safety interventions and effective strategies for translating evidence into practice. His work has appeared in leading journals, including the New England Journal of Medicine and the Journal of the American Medical Association. Of note to this audience, one of the articles in JAMA involved an analysis of approximately 40 years of autopsy studies to show that autopsy continues to detect clinically important missed diagnoses in a substantial proportion of decedents.
Dr. Shojania has also led a number of educational initiatives in patient safety, including a series of 13 case-based articles in Annals of Internal medicine on issues related to healthcare quality, two patient safety websites produced for the US Agency for Healthcare Research and Quality, which receive over 100,000 visits each month, and a book on patient safety for a general audience that received excellent reviews in the New York Times and Journal of the American Medical Association, and has sold over 40,000 copies. In 2004, Dr. Shojania received one of the John M. Eisenberg Patient Safety Awards from the US Joint Commission for the Accreditation of Healthcare Organizations and the National Quality Forum for work in patient safety that has had an impact at a national level.
-------------------------------------------

References to Greek Mythology in the Vernacular of Pathology: Allusions of Form and Fate

David Grynspan, University of Manitoba and Winnipeg Health Sciences Centre, Winnipeg, Manitoba

Click here for Objectives of this presentation

At the conclusion of this session, participants will:
• Appreciate the use of mythology in name some pathological entities and the reasons and traditions behind this usage;
• Have a better and more profound understanding of several terms such as “Triton tumor”, “syringome”, “syrenomelia” and “Ondine’s Curse”;
• Debate as to why Greek mythology may be an appropriate realm from which to draw names for such terms.
-------------------------------------------

John R. Srigley, Credit Valley Hospital, Mississauga, Ontario, and McMaster University, Hamilton, Ontario
Lee Fairclough, Vice-President Knowledge Management, Canadian Partnership Against Cancer

Cancer pathology reporting serves as the foundation for tumour staging and cancer system surveillance, planning, monitoring and quality improvement. Synoptic cancer pathology reporting has also been shown to enhance patient care by improving efficiency of clinical processes (Hammond EH, Flinner RL. Arch Pathol Lab Med 121:1171-1175, 1997) and completeness of reports (Srigley JR et al Mod Pathol 20:Suppl 2,185A, 2007).
In collaboration with the Canadian Partnership against Cancer, the Canadian Association of Pathologists is proposing to develop a strategy to adopt and implement a pan-Canadian standard for cancer pathology reporting.
 

Click here for Objectives of this presentation

• To provide an overview of the key elements of quality in cancer pathology reporting;
• To profile the College of American Pathologists cancer pathology reporting standard and its evolution;
• To highlight the experiences and key lessons learned in implementing the College of American Pathologists cancer reporting standard in one Canadian jurisdiction;
• To offer an opportunity for input and advice on the strategy for the adoption of a pan-Canadian cancer pathology reporting standard.
-------------------------------------------

Click here: Dr. John R. Srigley biography

John R. Srigley
Dr. John R. Srigley is Head of the Pathology and Laboratory Medicine Program at Cancer Care Ontario. He also represents Cancer Care Ontario on the Cancer Committee of the College of American Pathologists, a group that has developed internationally recognized cancer checklists for synoptic reporting. Dr. Srigley has championed the role of the pathologist as diagnostic oncologist and has been a leader in the standardization of cancer pathology reporting and Her-2 testing in Ontario. He has also worked with the Canadian Partnership Against Cancer (CPAC) to encourage interprovincial initiatives in synoptic pathology and surgery reporting. Dr. Srigley is a graduate of the Faculty of Medicine, University of Toronto. Following oncologic pathology training at the University of Toronto and MD Anderson Cancer Centre in Houston, Dr. Srigley practiced for twelve years at the Sunnybrook Health Science Centre where he was Director of Surgical Pathology. Currently, he is a staff pathologist at Credit Valley Hospital and Professor in the Department of Pathology and Molecular Medicine at McMaster University. Dr. Srigley is an international consultant and educator in the field of urologic pathology and has contributed over 200 publications to the literature. He is an author of two recent textbooks on the pathology of prostate cancer including the Armed Forces Institute of Pathology Fascicle. Dr. Srigley is also a co-author of the 2004 WHO Blue Book on Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. His research interests mainly revolve around clinicopathologic and translational studies of urologic tumours.
-------------------------------------------

Click here: Lee Fairclough biography

Lee Fairclough
A radiation therapist, Lee has enjoyed a successful career leading innovative informatics and knowledge management initiatives in the cancer control field. Before joining the Partnership she served as Director, Toronto Regional Cancer Programme, as well as Informatics and Administration Director, Clinical Research Unit, at Princess Margaret Hospital. She also brings to her new role experience working at the Joint Policy and Planning Committee of the Ministry of Health and Long Term Care and the Ontario Hospital Association.
Lee has an undergraduate biology and mathematics degree from McMaster University and a master’s of Health Science, Health Administration, from the University of Toronto. She was the recipient of the Robert Wood Johnson Award for her graduate studies.
-------------------------------------------

Chair: Barry Gallagher, James Paton Memorial Hospital, Gander, Newfoundland

PINS and its Mimics

Susan Robertson, The Ottawa Hospital, Ottawa, Ontario

Click here for Objectives of this presentation

Learning Objectives:
• Review of the morphological (light and immunohistochemical features) of High grade PIN;
• Review of the common histologic mimickers of High Grade PIN.
-------------------------------------------

Click here: Dr. Susan J. Robertson biography

Susan J. Robertson
Trained at Ottawa University Medical School and returned there in 1989 after several years in New Brunswick.
Specialty interests include the Pathology of Genitourinary, Breast and Medical Renal disease. Dr. Robertson is currently teaching at Ottawa. She is concentrated in genitourinary and medical kidney disease and her current research is predominantly on animal models of Diabetes. She is also the proud mother of three and is still married to their father (35 years and counting).
-------------------------------------------

Minimal Prostate Cancer and its Mimics

Kiril Trpkov, University of Calgary and Calgary Laboratory Services, Calgary, Alberta

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Discuss the clinical significance of minimal prostate cancer in the contemporary practice;
• Establish and list the minimal criteria for the diagnosis of prostate cancer and the necessary steps to arrive at a safe diagnosis;
• List and explain the common benign mimickers and the pitfalls in diagnosing minimal prostate cancer.
-------------------------------------------

Click here: Dr. Kiril Trpkov biography

Kiril Trpkov
Dr. Trpkov obtained his MD from the Medical School Skopje at the University Kiril and Metodij in Macedonia. He is currently an Associate Professor at the University of Calgary.
-------------------------------------------

Gleason Grading and Other Prognostic Factors on Needle Biopsy

David Grignon, Indiana University, Indianapolis, Indiana

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Apply the Gleason Grading System to prostate cancers in needle biopsy specimens;
• Discuss the current guidelines for reporting Gleason Grades in biopsy specimens;
• List the important morphologic features that should be included in a surgical pathology report of prostate cancer in a biopsy specimen.
-------------------------------------------

Handling and Reporting the Radical Prostatectomy Specimen: A Practical Approach

Speaker of the Royal College of Physicians and Surgeons of Canada: John R. Srigley, Credit Valley Hospital, Mississauga, Ontario, and McMaster University, Hamilton, Ontario

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Explain the macroscopic handling of the radical prostatectomy specimen;
• Understand the important prognostic factors (grade, stage, margin status, etc.) that should be included in a radical prostatectomy report;
• Explain the use of a synoptic report to convey important diagnostic and prognostic information derived from the radical prostatectomy specimen.
-------------------------------------------

Click here: Dr. John R. Srigley biography

John R. Srigley
Dr. John R. Srigley is Head of the Pathology and Laboratory Medicine Program at Cancer Care Ontario. He also represents Cancer Care Ontario on the Cancer Committee of the College of American Pathologists, a group that has developed internationally recognized cancer checklists for synoptic reporting. Dr. Srigley has championed the role of the pathologist as diagnostic oncologist and has been a leader in the standardization of cancer pathology reporting and Her-2 testing in Ontario. He has also worked with the Canadian Partnership Against Cancer (CPAC) to encourage interprovincial initiatives in synoptic pathology and surgery reporting.
Dr. Srigley is a graduate of the Faculty of Medicine, University of Toronto. Following oncologic pathology training at the University of Toronto and MD Anderson Cancer Centre in Houston, Dr. Srigley practiced for twelve years at the Sunnybrook Health Science Centre where he was Director of Surgical Pathology. Currently, he is a staff pathologist at Credit Valley Hospital and Professor in the Department of Pathology and Molecular Medicine at McMaster University. Dr. Srigley is an international consultant and educator in the field of urologic pathology and has contributed over 200 publications to the literature. He is an author of two recent textbooks on the pathology of prostate cancer including the Armed Forces Institute of Pathology Fascicle. Dr. Srigley is also a co-author of the 2004 WHO Blue Book on Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. His research interests mainly revolve around clinicopathologic and translational studies of urologic tumours.
-------------------------------------------

Chair: Marciano Reis, Sunnybrook and Women’s Hospital, Toronto, Ontario

From Biology to Morphology; What’s New in 2008 WHO Classification of Myeloid Neoplasms

Adnan Mansoor, University of Calgary, Calgary, Alberta

Click here for Objectives of this presentation

• This presentation will summarize the most recent scientific knowledge regarding myeloproliferative disorders (MPDs) with special reference to molecular lesions affecting the biology;
• A detailed comparison of new WHO classification (2008) with the previous classification (2001) of MPDs will be presented;
• A practical approach towards efficient utilization of ancillary techniques (immunohistochemistry; cytogenetics & molecular studies) in combination with morphology to correctly categorize these MPDs, according to new WHO classification system will also be discussed.
-------------------------------------------

Flow Cytometry for the Practicing Pathologist: Routine and Not So Routine Applications in Diagnostic Hematopathology

Ruth Padmore, The Ottawa Hospital, Ottawa, Ontario

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Summarize routine applications of flow cytometry;
• List non-routine applications of flow cytometry;
• Compare the diagnostic utility of routine and non-routine flow cytometry testing.
-------------------------------------------

Click here: Dr. Ruth Padmore biography

Ruth Padmore
Dr. Ruth Padmore received her medical degree from Dalhousie University. She is certified in Anatomical Pathology (residency at the University of Toronto) and Hematological Pathology (residency at the University of Ottawa). Prior to joining the faculty of the Ottawa Hospital, as a staff Hematopathologist in 2001, she completed a PhD at Harvard University, practiced surgical oncologic pathology at Fox Chase Cancer Centre, Philadelphia, and completed fellowship training in Hematopathology at the University of Michigan, Ann Arbor.
Dr. Padmore is an Associate Professor of Pathology and Laboratory Medicine at the University of Ottawa. As a staff Hematopathologist at the Ottawa Hospital, she is responsible for the day-to-day operations of the Flow Cytometry Laboratory, at the Ottawa Hospital, General Campus. She has a special interest in diagnostic Hematopathology and teaching.
-------------------------------------------

Tumors of the Kidney and Urinary Bladder

David Grignon, Centennial Professor of Pathology, Professor, Department of Pathology and Laboratory Medicine, Vice Chair for Clinical Programs, Indiana University School of Medicine, Indianapolis, Indiana

Click here for Objectives of this presentation

At the conclusion of this session, participants will be able to:
• Apply histologic criteria and immunohistochemistry to resolve differential diagnosis problems in epithelial kidney tumors;
• Diagnose newly described tumors of the kidney;
• Diagnose clinically important histologic variants of urothelial carcinoma.
-------------------------------------------